Sutton Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-53
Closed -$4.88K 865
2023
Q1
$4.88K Sell
53
-1,882
-97% -$164K ﹤0.01% 528
2022
Q4
$176K Hold
1,935
0.07% 188
2022
Q3
$147K Buy
1,935
+983
+103% +$81.5K 0.06% 199
2022
Q2
$80.5K Buy
952
+446
+88% +$39.1K 0.03% 273
2022
Q1
$44.4K Buy
506
+453
+855% +$39.2K 0.02% 438
2021
Q4
$4.64K Hold
53
﹤0.01% 1084
2021
Q3
$4.33K Hold
53
﹤0.01% 1074
2021
Q2
$4.84K Hold
53
﹤0.01% 1051
2021
Q1
$4.53K Hold
53
﹤0.01% 1028
2020
Q4
$5K Hold
53
﹤0.01% 979
2020
Q3
$4.61K Hold
53
﹤0.01% 948
2020
Q2
$4.63K Hold
53
﹤0.01% 922
2020
Q1
$4.37K Hold
53
﹤0.01% 857
2019
Q4
$5.02K Hold
53
﹤0.01% 947
2019
Q3
$4.61K Hold
53
﹤0.01% 958
2019
Q2
$4.84K Sell
53
-6
-10% -$508 ﹤0.01% 938
2019
Q1
$5.09K Hold
59
﹤0.01% 931
2018
Q4
$4.55K Hold
59
﹤0.01% 901
2018
Q3
$4.57K Hold
59
﹤0.01% 905
2018
Q2
$4K Hold
59
﹤0.01% 945
2018
Q1
$4.29K Hold
59
﹤0.01% 936
2017
Q4
$4.45K Hold
59
﹤0.01% 901
2017
Q3
$4.55K Hold
59
﹤0.01% 887
2017
Q2
$4.42K Hold
59
﹤0.01% 891
2017
Q1
$3.94K Hold
59
﹤0.01% 873
2016
Q4
$3.86K Hold
59
﹤0.01% 874
2016
Q3
$4.18K Hold
59
﹤0.01% 854
2016
Q2
$4.37K Sell
59
-391
-87% -$27K ﹤0.01% 809
2016
Q1
$29.2K Buy
+450
New +$30.6K 0.03% 343

Other funds holding NVS

Sutton Wealth Advisors's NVS Position: Q2 2023 in Review

Sutton Wealth Advisors sold out of Novartis (NVS) in Q2 2023, closing a stake of 53 shares — an estimated $4.88K sold.

Sutton Wealth Advisors first reported a position in NVS in Q1 2016 and held it in 29 quarters. The position peaked at $176K in Q4 2022. 1,203 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • Sutton Wealth Advisors reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 53 Novartis shares in Q2 2023, an estimated $4.88K.
  • Sutton Wealth Advisors first reported a position in Novartis in Q1 2016 and held it in 29 quarters.
  • Sutton Wealth Advisors's Novartis position peaked at $176K in Q4 2022.
  • 1,203 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on Sutton Wealth Advisors's 13F filing for Q2 2023, filed 8 Nov 2023.